What is Perry Baromedical?
With a legacy spanning over five decades, Perry Baromedical operates as a specialized manufacturer and service provider of hyperbaric oxygen therapy systems. The company maintains a robust portfolio that encompasses monoplace, dualplace, and multiplace hyperbaric chambers, alongside essential medical accessories. Beyond hardware production, the organization distinguishes itself through comprehensive facility design, rigorous preventative maintenance protocols, and specialized training programs for medical professionals. Their market position is defined by a focus on high-quality engineering and long-term reliability, catering to the complex needs of modern healthcare facilities and clinical practitioners globally.
How much funding has Perry Baromedical raised?
Perry Baromedical has raised a total of $520K across 2 funding rounds:
Debt
$150K
Debt
$370K
Debt (2020): $150K with participation from PPP
Debt (2021): $370K led by PPP
Key Investors in Perry Baromedical
PPP
Public-Private Partnership
What's next for Perry Baromedical?
The recent influx of capital is expected to accelerate Perry Baromedical's strategic initiatives, particularly in the areas of facility expansion and technological refinement of their hyperbaric equipment. As the demand for advanced therapeutic systems grows, the company is well-positioned to enhance its service delivery model and broaden its footprint in the medical device sector. Future growth will likely focus on integrating next-generation safety features and optimizing the lifecycle management of their installed base, ensuring that they remain a preferred partner for hospitals and specialized clinics seeking to upgrade their hyperbaric infrastructure.
See full Perry Baromedical company page
